CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Planned sale Chief Financial Officer sold 672 shares at $32.57 ($21,887)
- 4 Planned sale Principal Accounting Officer sold 1,214 shares at $32.57 ($39,540)
- 4 Planned sale Chief Executive Officer sold 4,156 shares at $32.57 ($135,361)
- 4 Planned sale Chief Legal Officer sold 2,642 shares at $32.57 ($86,050)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 69,329 shares at an average $34.67 ($2,403,592)
- 4 Open-market sale Director sold 68,142 shares at an average $33.09 ($2,254,951)
- 4 Open-market sale Principal Accounting Officer sold 504 shares at $26.63 ($13,422)
- 4 Planned sale Chief Medical Officer sold 642 shares at $25.14 ($16,140)
- 4 Planned sale Chief Legal Officer sold 545 shares at $25.14 ($13,701)
- 4 Planned sale Principal Accounting Officer sold 273 shares at $25.14 ($6,863)
- 4 Planned sale Chief Legal Officer sold 1,708 shares at $21.64 ($36,961)
- 4 Planned sale Chief Medical Officer sold 1,708 shares at $21.64 ($36,961)
- 4 Planned sale Chief Financial Officer sold 1,886 shares at $21.64 ($40,813)
- 4 Planned sale Director sold 10,722 shares at $21.64 ($232,024)
- 4 Planned sale Chief Executive Officer sold 7,635 shares at $21.64 ($165,221)
- 4 Planned sale Chief Commercial Officer sold 1,618 shares at $21.64 ($35,014)
- 4 Planned sale Chief Executive Officer sold 12,066 shares at $22.99 ($277,397)
- 4 Planned sale Director sold 8,391 shares at $22.99 ($192,909)
- 4 Planned sale Chief Legal Officer sold 1,163 shares at $22.99 ($26,737)
Page 7 of 38 · 758 filings